<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the relationship between neuropilin 2 (NRP-2) and lymphangiogenesis and <z:e sem="disease" ids="C0024232" disease_type="Neoplastic Process" abbrv="">lymphatic metastasis</z:e> of human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), as well as the expression of NRP-2 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 55 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, adjacent and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues of surgical resection were randomly selected at our hospital from March 2010 to January 2012 </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> pathological findings were confirmed by histopathology </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of NRP-2 was detected with reverse transcription (RT)-PCR and immunohistochemistry in parenchymatous and surrounding malignant tissues </plain></SENT>
<SENT sid="4" pm="."><plain>Then lymphangiogenesis was marked with D2-40 monoclonal antibody and microlymphatic density (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MLD</z:e>) counted </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Significant differences of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MLD</z:e> existed between those of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> region (39 ± 19) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> margin (53 ± 26, P &lt; 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Both the number and shape of lymphangiogenesis were different between the parenchymatous and surrounding tissues </plain></SENT>
<SENT sid="7" pm="."><plain>The expression of NRP-2 had a positive correlation with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MLD</z:e> both at the protein level (r = 0.325, P &lt; 0.05) and at the gene level (r = 0.545, P = 0.000) </plain></SENT>
<SENT sid="8" pm="."><plain>And it was also correlated with the differentiation degree, infiltrative degree, lymphovascular invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and Dukes <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> staging (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The expression of NRP-2 may regulate lymphangiogenesis and it may play an important role in the incidence and development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>